Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay

The Elecsys® Anti-SARS-CoV-2 S immunoassay (Roche Diagnostics International Ltd, Rotkreuz, Switzerland) has been developed for the detection of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein. We evaluated the assay performance using samples from seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Riester, Elena, Findeisen, Peter, Hegel, J. Kolja, Kabesch, Michael, Ambrosch, Andreas, Rank, Christopher M., Pessl, Florina, Laengin, Tina, Niederhauser, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393518/
https://www.ncbi.nlm.nih.gov/pubmed/34461153
http://dx.doi.org/10.1016/j.jviromet.2021.114271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393518/
https://www.ncbi.nlm.nih.gov/pubmed/34461153
http://dx.doi.org/10.1016/j.jviromet.2021.114271

Ejemplares similares